Premature ovarian insufficiency: a toolkit for the primary care physician

References

• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric 2020;23:426–46
   PubMed Web of Science ®Google Scholar
• Maclaran K, Panay N. Current concepts in premature ovarian insufficiency. Womens Health (Lond Engl) 2015;11:169–82
   PubMedGoogle Scholar
• Mishra GD, Chung HF, Cano A, et al. EMAS position statement: predictors of premature and early natural menopause. Maturitas 2019;123:82–8
   PubMed Web of Science ®Google Scholar
• Vujovic S, Brincat M, Erel T, et al. EMAS position statement: managing women with premature ovarian failure. Maturitas 2010;67:91–3
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• NICE Guideline [NG23]: Menopause diagnosis and management. //www.nice.org.uk/guidance/ng23 [last accessed 13 Sep 2020]
   Google Scholar
• Webber L, Davies M, Anderson R, et al. European Society for Human Reproduction and Embryology (ESHRE) guideline group on POI. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016;31:926–37
   PubMed Web of Science ®Google Scholar
• La Marca A, Marzotti S, Brozetti A, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. J Clin Endocrinol Metab 2009;94:3816–23
   PubMed Web of Science ®Google Scholar
• Anderson RA, Mansi J, Coleman RE, Adamson DJA, Leonard RCF. The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer. Eur J Cancer 2017;87:58–64
   PubMed Web of Science ®Google Scholar
• Nelson SM, Klein BM, Arce JC. Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials. Fertil Steril 2015;103:923–30
   PubMed Web of Science ®Google Scholar
• Huhtaniemi I, Alevizaki M. Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 2006;20:561–76
   PubMed Web of Science ®Google Scholar
• Hoshino A, Horvath S, Sridhar A, Chitsazan A, Reh TA. Synchrony and asynchrony between an epigenetic clock and developmental timing. Sci Rep 2019;9:3770
   PubMed Web of Science ®Google Scholar
• Jiao X, Qin C, Li J, et al. Cytogenetic analysis of 531 Chinese women with premature ovarian failure. Hum Reprod 2012;27:2201–7
   PubMed Web of Science ®Google Scholar
• Rossetti R, Ferrari I, Bonomi M, Persani L. Genetics of primary ovarian insufficiency. Clin Genet 2017;91:183–98
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: screening for fragile X syndrome. Obstet Gynecol 2006;107:1483–5
   PubMedGoogle Scholar
• Heddar A, Dessen P, Flatters D, Misrahi M. Novel STAG3 mutations in a Caucasian family with primary ovarian insufficiency. Mol Genet Genomics 2019;294:1527–34
   PubMed Web of Science ®Google Scholar
• Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet 2019;36:2207–15
   PubMed Web of Science ®Google Scholar
• Silva CA, Yamakami LY, Aikawa NE, et al. Autoimmune primary ovarian insufficiency. Autoimmun Rev 2014;13:427–30
   PubMed Web of Science ®Google Scholar
• Tariq S, Anderson J, Burns F, Delpech V, Gilson R, Sabin C. The menopause transition in women living with HIV: current evidence and future avenues of research. J Virus Erod 2016;2:114–16
   PubMed Web of Science ®Google Scholar
• Vabre P, Gatimel N, Moreau J, et al. Environmental pollutants, a possible etiology for premature ovarian insufficiency: a narrative review of animal and human data. Environ Health 2017;16:37
   PubMed Web of Science ®Google Scholar
• Thakur M, Feldman G, Puscheck EJ. Primary ovarian insufficiency in classic galactosemia: current understanding and future research opportunities. J Assist Reprod Genet 2018;35:3–16
   PubMed Web of Science ®Google Scholar
• Panay N, Fenton A. Iatrogenic menopause following gynecological malignancy: time for action! Climacteric 2016;19:1–2
   PubMed Web of Science ®Google Scholar
• Spears N, Lopes F, Stefansdottir A, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update 2019;25:673–93
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Palla G, Gambacciani M, Simoncini T. Tailored hormonal approach in women with premature ovarian insufficiency. Climacteric 2020;23:3–8
   PubMed Web of Science ®Google Scholar
• Paschou SA, Augoulea A, Lambrinoudaki I. Premature ovarian insufficiency. Eur Gynecol Obstet 2020;2:5–9
   Google Scholar
• Armeni E, Lambrinoudaki I, Ceausu I, et al. Maintaining postreproductive health: a care pathway from the European Menopause and Andropause Society (EMAS). Maturitas 2016;89:63–72
   PubMed Web of Science ®Google Scholar
• Yeganeh L, Boyle JA, Wood A, Teede H, Vincent AJ. Menopause guideline appraisal and algorithm development for premature ovarian insufficiency. Maturitas 2019;130:21–31
   PubMed Web of Science ®Google Scholar
• Cattoni A, Parissone F, Porcari I, et al. Hormonal replacement therapy in adolescents and young women with chemo- or radio-induced premature ovarian insufficiency: practical recommendations. Blood Rev 2020:100730
   PubMed Web of Science ®Google Scholar
• Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc 2017;92:1842–9
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause 2020;27:976–92
   PubMed Web of Science ®Google Scholar
• Swica Y, Warren MP, Manson JE, et al. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials. Menopause 2018;25:753–61
   PubMed Web of Science ®Google Scholar
• Smith NL, Blondon M, Wiggins KL, et al. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Intern Med 2014;174:25–31
   PubMed Web of Science ®Google Scholar
• Henzl MR, Loomba PK. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. J Reprod Med 2003;48:525–40
   PubMed Web of Science ®Google Scholar
• Cartwright B, Robinson J, Seed PT, Fogelman I, Rymer J. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomized controlled trial of the effects on bone mineral density. J Clin Endocrinol Metab 2016;101:3497–505
   PubMed Web of Science ®Google Scholar
• Gazarra LBC, Bonacordi CL, Yela DA, Benetti-Pinto CL. Bone mass in women with premature ovarian insufficiency: a comparative study between hormone therapy and combined oral contraceptives. Menopause 2020;27:1110–16
   PubMed Web of Science ®Google Scholar
• Edelman A, Micks E, Gallo MF, et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev 2014;7:CD004695
   PubMed Web of Science ®Google Scholar
• Hugon-Rodin J, Gompel A, Plu-Bureau G. Epidemiology of hormonal contraceptives-related venous thromboembolism. Eur J Endocrinol 2014;171:R221–30
   PubMed Web of Science ®Google Scholar
• Langrish JP, Mills NL, Bath LE, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009;53:805–11
   PubMed Web of Science ®Google Scholar
• Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004;89:3907–13
   PubMed Web of Science ®Google Scholar
• Fournier A, Mesrine S, Dossus L, Boutron-Ruault MC, Clavel-Chapelon F, Chabbert-Buffet N. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort. Breast Cancer Res Treat 2014;145:535–43
   PubMed Web of Science ®Google Scholar
• Canonico M, Plu-Bureau G, O’Sullivan MJ, et al. Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women’s Health Initiative Hormone Therapy clinical trials. Menopause 2014;21:214–20
   PubMed Web of Science ®Google Scholar
• Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2014;99:3489–510
   PubMed Web of Science ®Google Scholar
• Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the use of testosterone therapy for women. Climacteric 2019;22:429–34
   PubMed Web of Science ®Google Scholar
• Bidet M, Bachelot A, Bissauge E, et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011;96:3864–72
   PubMed Web of Science ®Google Scholar
• van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483–92
   PubMed Web of Science ®Google Scholar
• Sauer MV. Spontaneous pregnancy in women awaiting oocyte donation. J Reprod Med 1995;40:630–2
   PubMed Web of Science ®Google Scholar
• Rebar RW. Premature ovarian failure. Obstet Gynecol 2009;113:1355–63
   PubMed Web of Science ®Google Scholar
• Weghofer A, Barad D, Li J, Gleicher N. Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 2007;88:90–4
   PubMed Web of Science ®Google Scholar
• Jacquemont S, Hagerman RJ, Hagerman PJ, Leehey MA. Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1. Lancet Neurol 2007;6:45–55
   PubMed Web of Science ®Google Scholar
• Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456–65
   PubMed Web of Science ®Google Scholar
• Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril 2011;95:2251–6
   PubMed Web of Science ®Google Scholar
• Bryman I, Sylven L, Berntorp K, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril 2011;95:2507–10
   PubMed Web of Science ®Google Scholar
• Wallace WH, Thompson L, Anderson RA. Guideline Development Group. Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance. BMJ 2013;346:f1190
   PubMed Web of Science ®Google Scholar
• Signorello LB, Mulvihill JJ, Green DM, et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. JCO 2012;30:239–45
   PubMed Web of Science ®Google Scholar
• Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol 2010;116:1171–83
   PubMed Web of Science ®Google Scholar
• Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. BJOG 1999;106:1265–72
   Web of Science ®Google Scholar
• Signorello LB, Mulvihill JJ, Green DM, et al. Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study. Lancet 2010;376:624–30
   PubMed Web of Science ®Google Scholar
• Wo JY, Viswanathan AN. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 2009;73:1304–12
   PubMed Web of Science ®Google Scholar
• Taylor AE, Adams JM, Mulder JE, Martin KA, Sluss PM, Crowley WF. Jr,. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996;81:3615–21
   PubMed Web of Science ®Google Scholar
• Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure: a randomized, placebo-controlled trial. Fertil Steril 2007;87:858–61
   PubMed Web of Science ®Google Scholar
• Badawy A, Goda H, Ragab A. Induction of ovulation in idiopathic premature ovarian failure: a randomized double-blind trial. Reprod Biomed Online 2007;15:215–19
   PubMed Web of Science ®Google Scholar
• Ferrau F, Gangemi S, Vita G, Trimarchi F, Cannavo S. Pregnancy after azathioprine therapy for ulcerative colitis in a woman with autoimmune premature ovarian failure and Addison's disease: HLA haplotype characterization. Fertil Steril 2011;95:2430.e15–7
   Web of Science ®Google Scholar
• Sung L, Bustillo M, Mukherjee T, Booth G, Karstaedt A, Copperman AB. Sisters of women with premature ovarian failure may not be ideal ovum donors. Fertil Steril 1997;67:912–16
   PubMed Web of Science ®Google Scholar
• De Geyter C, Calhaz-Jorge C, Kupka MS, et al. ART in Europe, 2014: results generated from European registries by ESHRE: the European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod 2018;33:1586–601
   PubMed Web of Science ®Google Scholar
• Sunderam S, Kissin DM, Zhang Y, et al. Assisted reproductive technology surveillance - United States, 2016. MMWR Surveill Summ 2019;68:1–23
   PubMed Web of Science ®Google Scholar
• Abdalla HI, Billett A, Kan AK, et al. Obstetric outcome in 232 ovum donation pregnancies. BJOG 1998;105:332–7
   Web of Science ®Google Scholar
• Pados G, Camus M, Van Steirteghem A, Bonduelle M, Devroey P. The evolution and outcome of pregnancies from oocyte donation. Hum Reprod 1994;9:538–42
   PubMed Web of Science ®Google Scholar
• Nelson SM, Lawlor DA. Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles. PLoS Med 2011;8:e1000386
   PubMed Web of Science ®Google Scholar
• Stoop D, Baumgarten M, Haentjens P, et al. Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis. Reprod Biol Endocrinol 2012;10:42
   PubMed Web of Science ®Google Scholar
• Hagman A, Loft A, Wennerholm UB, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with turner syndrome: a Nordic cohort study. Hum Reprod 2013;28:1598–609
   PubMed Web of Science ®Google Scholar
• Suzuki N, Yoshioka N, Takae S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod 2015;30:608–15
   PubMed Web of Science ®Google Scholar
• Zhai J, Yao G, Dong F, et al. In vitro activation of follicles and fresh tissue auto-transplantation in primary ovarian insufficiency patients. J Clin Endocrinol Metab 2016;101:4405–12
   PubMed Web of Science ®Google Scholar
• Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145–50
   PubMed Web of Science ®Google Scholar
• Grieve KM, McLaughlin M, Dunlop CE, Telfer EE, Anderson RA. The controversial existence and functional potential of oogonial stem cells. Maturitas 2015;82:278–81
   PubMed Web of Science ®Google Scholar
• White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 2012;18:413–21
   PubMed Web of Science ®Google Scholar
• Steiner AZ, Herring AH, Kesner JS, et al. Antimüllerian hormone as a predictor of natural fecundability in women aged 30-42 years. Obstet Gynecol 2011;117:798–804
   PubMed Web of Science ®Google Scholar
• Practice Committees of American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril 2013;99:37–43
   PubMed Web of Science ®Google Scholar
• Cobo A, García-Velasco JA, Coello A, Domingo J, Pellicer A, Remohí J. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016;105:755–64 e8
   PubMed Web of Science ®Google Scholar
• Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril 2014;101:1237–43
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet 2015;32:1167–70
   PubMed Web of Science ®Google Scholar
• Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis. Reprod Sci 2017;24:1111–20
   PubMed Web of Science ®Google Scholar
• Moawad NS, Santamaria E, Rhoton-Vlasak A, Lightsey JL. Laparoscopic ovarian transposition before pelvic cancer treatment: ovarian function and fertility preservation. J Minim Invasive Gynecol 2017;24:28–35
   PubMed Web of Science ®Google Scholar
• Chen H, Xiao L, Li J, Cui L, Huang W. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Cochrane Database Syst Rev 2019;3:CD008018
   PubMed Web of Science ®Google Scholar
• Oktay K, Bedoschi G, Berkowitz K, et al. Fertility preservation in women with turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol 2016;29:409–16
   PubMed Web of Science ®Google Scholar
• Liao KL, Wood N, Conway GS. Premature menopause and psychological well-being. J Psychosom Obstet Gynaecol 2000;21:167–74
   PubMed Web of Science ®Google Scholar
• Mann E, Singer D, Pitkin J, Panay N, Hunter MS. Psychosocial adjustment in women with premature menopause: a cross-sectional survey. Climacteric 2012;15:481–9
   PubMed Web of Science ®Google Scholar
• Orshan SA, Ventura JL, Covington SN, Vanderhoof VH, Troendle JF, Nelson LM. Women with spontaneous 46,XX primary ovarian insufficiency (hypergonadotropic hypogonadism) have lower perceived social support than control women. Fertil Steril 2009;92:688–93
   PubMed Web of Science ®Google Scholar
• Orshan SA, Furniss KK, Forst C, Santoro N. The lived experience of premature ovarian failure. J Obstet Gynecol Neonatal Nurs 2001;30:202–8
   PubMedGoogle Scholar
• Schmidt PJ, Cardoso GM, Ross JL, Haq N, Rubinow DR, Bondy CA. Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. JAMA 2006;295:1374–6
   PubMed Web of Science ®Google Scholar
• Deeks AA, Gibson-Helm M, Teede H, Vincent A. Premature menopause: a comprehensive understanding of psychosocial aspects. Climacteric 2011;14:565–72
   PubMed Web of Science ®Google Scholar
• Groff AA, Covington SN, Halverson LR, et al. Assessing the emotional needs of women with spontaneous premature ovarian failure. Fertil Steril 2005;83:1734–41
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Luff JA, Haq NA, et al. Depression in women with spontaneous 46,XX primary ovarian insufficiency. J Clin Endocrinol Metab 2011;96:E278–87
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375–82
   PubMed Web of Science ®Google Scholar
• Schmidt PJ, Ben Dor R, Martinez PE, et al. Effects of estradiol withdrawal on mood in women with past perimenopausal depression: a randomized clinical trial. JAMA Psychiatry 2015;72:714–26
   PubMed Web of Science ®Google Scholar
• Marsh WK, Bromberger JT, Crawford SL, et al. Lifelong estradiol exposure and risk of depressive symptoms during the transition to menopause and postmenopause. Menopause 2017;24:1351–9
   PubMed Web of Science ®Google Scholar
• Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause 2018;25:1069–85
   PubMed Web of Science ®Google Scholar
• Nappi RE, Cucinella L, Martini E, et al. Sexuality in premature ovarian insufficiency. Climacteric 2019;22:289–95
   PubMed Web of Science ®Google Scholar
• Graziottin A, Basson R. Sexual dysfunction in women with premature menopause. Menopause 2004;11:766–77
   PubMed Web of Science ®Google Scholar
• Janse F, Tanahatoe SJ, Eijkemans MJ, Fauser BC. Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update 2012;18:405–19
   PubMed Web of Science ®Google Scholar
• Soman M, Huang LC, Cai WH, et al. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis. Menopause 2019;26:78–93
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol 2019;7:754–66
   PubMed Web of Science ®Google Scholar
• Kalantaridou SN, Vanderhoof VH, Calis KA, Corrigan EC, Troendle JF, Nelson LM. Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency. Fertil Steril 2008;90:1805–11
   PubMed Web of Science ®Google Scholar
• van der Stege JG, Groen H, van Zadelhoff SJ, et al. Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure. Menopause 2008;15:23–31
   PubMed Web of Science ®Google Scholar
• Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc 2012;87:187–93
   PubMed Web of Science ®Google Scholar
• Parish SJ, Hahn SR, Goldstein SW, et al. The International Society for the Study of Women's sexual health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc 2019;94:842–56
   PubMed Web of Science ®Google Scholar
• Bober SL, Recklitis CJ, Bakan J, Garber JE, Patenaude AF. Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention. J Sex Med 2015;12:189–97
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Christou K, Artzouchaltzi AM, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol 2019;180:41–50
   PubMed Web of Science ®Google Scholar
• Cooper GS, Sandler DP. Age at natural menopause and mortality. Ann Epidemiol 1998;8:229–35
   PubMed Web of Science ®Google Scholar
• Roeters van Lennep JE, Heida KY, Bots ML, Hoek A. collaborators of the Dutch Multidisciplinary Guideline Development Group on Cardiovascular Risk Management after Reproductive Disorders. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol 2016;23:178–86
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Siolos P, Gkekas NK, et al. Association between age at menopause and fracture risk: a systematic review and meta-analysis. Endocrine 2019;63:213–24
   PubMed Web of Science ®Google Scholar
• Paschou SA, Augoulea A, Lambrinoudaki I. Bone health care in women with breast cancer. Hormones (Athens) 2020;19:171–8
   PubMedGoogle Scholar
• Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG. Type 2 diabetes and osteoporosis: a guide to optimal management. J Clin Endocrinol Metab 2017;102:3621–3
   PubMed Web of Science ®Google Scholar